Mesoblast corporate update and financial results webcast

New york, feb. 24, 2022 (globe newswire) -- mesoblast limited (nasdaq:meso; asx:msb), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended december 31, 2021.

MESO Ratings Summary

MESO Quant Ranking